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Methods: BBL was evaluated in a randomized controlled trial in 176 middle-aged adults with .2
risk factors and,2 protective factors for Alzheimer’s disease (AD) assessed on a brief screening in-
strument. Participants were randomized to BBL, BBL plus face-to-face group sessions (BBL 1 FF)
or active control (control). Score on the Australian National University-Alzheimer’s disease risk in-
dex (ANU-ADRI), a validated index of AD risk, was the primary outcome measure assessed at base-
line, 12, and 26 weeks.
Results: Agroup by time interaction at 26 weeks showed a significant reduction in ANU-ADRI score
for BBL compared with control. Planned contrasts showed the BBL and BBL 1 FF groups had
improvement in ANU-ADRI scores at 12 weeks (BBL 1 FF: z 5 20.25; P 5 .021; BBL:
z 5 20.25; P 5 .008) and 26 weeks (BBL 1 FF: z 5 20.48; P , .001; BBL: z 5 20.28;
P 5 .004) due to increase in protective factors.
Conclusions: This short intervention resulted in dementia risk reduction. Online dementia risk
reduction interventions show promise for reducing the overall dementia risk in middle-aged adults
with multiple risk factors.
Clinical Trial Registration: The study is registered under Trial Registration: Reg. #
ACTRN12612000147886.
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Dementia is highly prevalent with .30% of adults
aged .80 years developing the syndrome [1]. No cure is
available for neurodegenerative conditions causing demen-
tia and recent clinical trials of potential treatments havest and disclosures: None.
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commons.org/licenses/by-nc-nd/4.0/).been disappointing [2]. It has been estimated that an achiev-
able 10%–25% reduction in seven key risk factors could pre-
vent 1.1–3.0 million Alzheimer’s disease (AD) cases
internationally per annum [3]. There is now strong evidence
linking modifiable risk factors in mid-life with dementia in
late-life, justifying risk reduction trials among middle-
aged adults with multiple risk factors [4,5].
Despite the success of online interventions for treating
depression [6], alcohol misuse [7], and preventing obesity
[8], online interventions have not yet been trialed in the field
of dementia risk reduction. We therefore developed andimer’s Association. This is an open access article under the CC BY-NC-ND
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tion, to address multiple risk factors for AD using behavior
change principles. The intervention also provides education
about dementia, aiming to increase dementia literacy [9].
The aim of the study was to conduct a randomized controlled
trial to evaluate the effectiveness of BBL, and a version of
BBL including an additional face-to-face component
(BBL 1 FF), to reduce the risk of dementia.2. Methods
The trial protocol was published [10]. The trial was un-
dertaken in the city of Canberra, Australia in the community.
2.1. Study design
A randomized controlled trial to evaluate the effective-
ness of BBL and BBL 1 FF to reduce the risk of dementia
was undertaken. The trial involved three groups: (1) BBL;
(2) BBL 1 FF; and (3) active control (control). BBL and
BBL 1 FF undertook a 12-week intervention program. Par-
ticipants were followed up immediately postintervention
and 26 weeks postintervention.
2.2. Participants
Recruitment for this trial took place between July 2012
and March 2013 through advertisements to community
groups via radio and print media, as well as advertising fliers
in community health centers, community clubs, and through
word of mouth. Participants had to be cognitively healthy;
adults aged 50–60 years and living independently. Screening
for inclusion and exclusion criteria was conducted using a
structured telephone interview. Participants were required
to obtain a score .24 on the telephonic screening [11] to
exclude the presence of global cognitive impairment, have
access to a computer and internet connection at home;
English fluency; and a minimum of three of the following
risk factors: formal educational attainment at high school
level or less, overweight or obese body mass index (BMI),
a history of diabetes, hypertension, high cholesterol,
smoking, traumatic brain injury, and/or depression. Partici-
pants also needed to have a maximum of one protective
factor for AD including a protective level of physical activ-
ity, high consumption of fish, and cognitive engagement
(Supplementary Table 1). The screening method identified
fewer protective factors than the full assessment. Hence,
the final sample included participants with more than one
protective factor.
Participants with a history of neurologic or psychiatric
conditions likely to substantially affect cognition (e.g.,
recent stroke, epilepsy, schizophrenia), sensory deficits or
mobility limitations that would prevent or substantially
restrict the delivery of the assessment or intervention (e.g.,
uncorrected substantial loss of hearing or vision, severe
physical disability), as well as other significant health prob-
lems (e.g., recent cardiovascular event, renal failure, treat-ment for cancer) were excluded. The study protocol was
approved by the ANU Human Research Ethics. Participants
provided written, informed consent.2.3. Interventions
Participants were randomized to receive BBL, BBL1 FF,
or the control condition (ratio 1:1:1). The control was used to
counter the effects of increased computer use in the BBL
condition which may be cognitively stimulating and to con-
trol for the provision of health information. In all groups, the
intervention was delivered over a 12-week period.
2.3.1. Group 1: BBL
The BBL program was delivered through a dedicated and
specifically designedWeb site and comprised sevenmodules
consecutively, each delivered once per week and lasting
approximately 1 hour. After the first 7 weeks, participants
completed self-directed online activities on the BBL Web
site focused on activity and goal monitoring and revision
for the remaining 5 weeks. The first two modules were
educational and covered general dementia literacy issues
and familiarization with risk and protective factors for de-
mentia. Modules 3–7 each focussed on physical activity,
diet, social engagement, cognitive engagement, and man-
agement of chronic conditions. They were developed in a
standardized “bottom-up” fashion using a published taxon-
omy of behavior-change techniques (BCTs [12]) and the
theoretical domains framework. The content of these mod-
ules was tailored to individuals’ profiles using an automated
algorithm that selected BCTs for presentation on the basis of
whether the particular risk/protective factor the module ad-
dressed applied to participants. The tailoring algorithm
further used participants’ responses to several questions, pre-
sented at the start of each module, measuring 14 behavioral
determinants [13]. For example, a person who was classified
as sedentary on the basis of his/her responses on the Austra-
lian National University-Alzheimer’s disease risk index
(ANU-ADRI) (risk factor), and who did not regard
himself/herself as optimistic regarding their prospect of
change in the area of physical activity (behavioral determi-
nant in relation to physical activity), was presented with a
BCT focused on learned optimism and the relationship
between optimism and a range of health outcomes. The pro-
gram was developed so that participants were only able to
access the relevant component of the intervention at a given
time. Themodules became active, one per week, on the same
day (usually Sunday) for the first 7 weeks. Participants
received up to two automatic reminders to complete a
module and were then sent a text message before finally
being phoned.
2.3.2. Group 2: BBL 1 FF
Participants in the BBL1 FF group completed the online
program in the same way as the BBL-only group, and in
addition attended five face-to-face sessions conducted in
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5, 7, 9, and 12). The content of the group sessions was orga-
nized around the themes of the corresponding online mod-
ules. The sessions included facilitated discussions of the
various risk factors for dementia, goal setting, and barriers
to behavior change. To monitor and evaluate fidelity of
delivery, the sessions were prescripted and a subset was
recorded and subsequently analyzed.
Besides the face-to-face component, contact with partic-
ipants in this group was identical to the contact made with
participants in the BBL group with the exception that partic-
ipants in this group also received additional emails to remind
them of upcoming face-to-face sessions.
2.3.3. Group 3: Active control (control)
The control group did not access the trial Web site but
received weekly emails containing links to health-related
Web Sites, videos, and news items, focusing on topics
related to dementia and general health and lifestyle with
the material organized around the same themes as the ones
included in the online BBL program. Participants were
encouraged to spend an hour each week browsing through
the material. Links did not lead to sites using identifiable
BCTs. This group did not receive reminders or other emails,
and it was not possible to assess adherence.2.4. Randomization and blinding
A permuted block randomization sequence comprising
block sizes of 30 stratified by gender was used. The alloca-
tion sequence was generated by an independent researcher
following the baseline assessments and was not known to
the study team at the time of enrolment and baseline assess-
ment. To prevent evaluation bias, research staff conducting
the psychological, physical, and cognitive outcome assess-
ments, as well as those involved in the analysis of pathology
data remained blind to participants’ group allocation. The
contact person for participants’ Web site queries, access
issues, and technical difficulties was independent of all base-
line or follow-up data. All participants were informed that
they were being randomly allocated to one of three study
groups and that one group may be more effective than others.
They were also notified at the start of the study that one of
these groups involved several face-to-face sessions. Partici-
pants were unaware of the study hypotheses, thus reducing
the chances of response bias.2.5. Outcome measures
Assessments for outcomes were undertaken at 12 and
26 weeks postintervention (26 weeks) postbaseline.
2.5.1. Primary outcome
The primary outcome measure was the ANU-ADRI [14],
a validated instrument assessing individual risk exposure
profile developed after a synthesis of meta-analyses ofvarious risk factors for AD reported in the literature. The
questionnaire covers several modifiable risk and protective
factors and is based on self-report. Risk factors include
age, sex, low education, diabetes, history of traumatic brain
injury, smoking, pesticide exposure, low social engagement,
and protective factors include high physical activity, high
cognitive activity, fish consumption (three or more times
per week), and light-to-moderate alcohol consumption
(Supplementary Table 1). Not all factors in the ANU-
ADRI were addressed by the intervention modules.
2.5.2. Secondary outcome
Dementia literacy using a previously described question-
naire [9] at the baseline, immediate postintervention, and
follow-up assessments. To measure dementia recognition,
participants were asked what condition the person in a
vignette might have. Participants were asked whether certain
behaviors would increase, decrease, or not make any differ-
ence to their chance of developing dementia. Together, these
were used to measure knowledge on risk and protective fac-
tors.
Other aspects of the trial are not considered here. (See
trial design article for full description [10]).2.6. Power
Sample size calculations were estimated using G*Power
(version 3.1.3). Because of the lack of published trials on AD
and dementia risk reduction, power estimations were based
on medium-effect sizes found for multidomain lifestyle in-
terventions in the primary prevention of cardiovascular dis-
ease [15]. To detect a medium effect in a three-group design
(1:1:1), with a 5% risk of type 1 error (a) and 80% power, a
total sample size of 159 persons is required. Amedium effect
(0.5 standard deviation [SD]) on the ANU-ADRI is 4.25
points on the scale as described previously [14]. This figure
is derived from the pooled SD of the ANU-ADRI from three
cohort studies with combined n of 4301; the Rush Memory
and Aging Study, the Kungsholmen Project, and the Cardio-
vascular Health Study. To account for attrition, a baseline
sample of 176 was recruited.2.7. Statistical analysis
Data were reviewed for outliers on the ANU-ADRI score
at each wave; none were detected with the distribution (SD,
range) remaining consistent at each measurement occasion.
Baseline characteristics were compared with analysis of
variance for continuous variables and chi-square tests for
categorical variables. Using an intent-to-treat approach,
random-effects linear models with random participant inter-
cepts with factors of intervention group (reference group:
active control) and occasion of measurement (reference
group: baseline observation) were used to evaluate change
in the ANU-ADRI. Contrasts of model parameters examined
differences in odds of change between intervention groups
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assess change in dementia literacy. ANU-ADRI scores
were standardized (mean5 0; SD5 1) to baseline to derive
effect sizes.3. Results
Participants were enrolled from July 2012 toMarch 2013,
and data collection was completed in September 2013. The
flow of participants is shown in Fig. 1. A total of 502 individ-
uals responded to advertisements and were assessed for
eligibility. Of these, 129 were excluded because they did
not meet criteria or refused and 373 consented to screening.
A further 10 could not then be contacted or refused screening
with 363 completing phone screening. Of these, 178 did not
meet screening criteria on the phone assessment and 185
were invited to assessment. A further 9 participants dropped
out of the study and 176 enrolled in the trial and were ran-
domized; 58 to BBL, 58 to BBL 1 FF, and 60 to the active
control. A total of seven participants withdrew during the
study intervention period: three reported time constraints,
three cited dissatisfaction with content, and one with un-
known reasons. Withdrawal patterns were similar between
groups (three in BBL, three in control, and one in
BBL-FF). In terms of retention, 136 (77.3% of the baseline
sample) and 135 (76.7%) completed a follow-up after the
12-week intervention and at the 26-week follow-up,
respectively.
Baseline characteristics are shown in Table 1. Partici-
pants had a mean age of 55.5 years (SD 5 2.96) and 18.1
(SD 5 3.56) years of education; 52.8% were female. The
most common risk factor was high BMI, present in 77.1%
of participants, followed by low cognitive engagement
(61.9%). Only a small proportion of the sample did not
engage in sufficient exercise to gain any protection
(12.5%). Of the sample, 18.8% did not eat sufficient fish to
gain any protection but only 5.7% ate enough fish to gain
the optimal protection based on epidemiologic studies
[16]. The BBL 1 FF group had significantly lower rates of
smoking compared with BBL and control groups
(Table 1). The groups did not differ in terms of baseline
cognitive function, clinical/laboratory markers of hyperten-
sion, cholesterol, or glycemia (Supplementary Table 2).
ANU-ADRI scores for each group reported by total, pro-
tective, and risk factor scores are shown online
(Supplementary Table 1). Results showed that the initial
telephone screening underestimated the number of protec-
tive factors compared with the full ANU-ADRI assessment
which meant the sample had than one protective factor on
average. However, the sample had much higher scores on
the ANU-ADRI than the population-based PATH Through
Life cohort aged 60–64 years from the same region which
had a mean ANU-ADRI score of 28.26 (baseline data,
SD 5 5.52; range 218 to 16; n 5 1638).
Table 2 shows the effect of the intervention by group and
time. A main effect of time indicated an overall improve-ment (reduction) on the ANU-ADRI score from baseline
to 12 weeks (b 5 20.19; standard error [SE] 5 0.17;
P , .01) and baseline to 26 weeks (b 5 20.28;
SE 5 0.07; P , .001). Although the inclusion of an interac-
tion between intervention arm and occasion of measurement
indicated both BBL and BBL-FF reported significant risk
reduction compared with control, these failed to reach statis-
tical significance and only the BBL at 26 weeks reported a
statistically significant difference from control (b 5 20.37
[SE 5 0.16] P , .05). Furthermore, repeated
cross-sectional analysis indicated there were no between-
group differences but BBL and BBL 1 FF improved signif-
icantly from baseline (Fig. 2).
When broken down by risk and protective factors
(Table 2), results showed that the change was due to an in-
crease in protective behaviors. Fig. 2 shows the decline in to-
tal ANU-ADRI score by group. Planned contrasts of the
changes within group indicated no significant changes in
control between baseline and time at 12 (P 5 .549) and
26 weeks (P 5 .388). In contrast, significant declines for
the BBL and BBL1 FF groups were reported between base-
line and both 12 (BBL 1 FF: z 5 20.25, P 5 .021; BBL:
z 5 20.25, P 5 .008) and 26 weeks postintervention
(BBL 1 FF: z 5 20.48, P , .001; BBL: z 5 20.28
P5 .004). Overall, there were no significant differences be-
tween groups at each wave but there were significant within
group changes for the BBL and BBL 1 FF groups
(Supplementary Fig. 1).
Among individual protective factors, improvements were
seen in reported level of fish consumption and cognitive
engagement. There was a significant increase in cognitive
engagement at 12 weeks postbaseline (odds ratio
[OR] 5 2.64; 95% confidence interval [CI], 1.21–5.77;
P 5 .015) and 26 weeks postintervention (OR 5 4.49;
95% CI, 1.97–10.25; P, .001) consistent between interven-
tion groups. Similarly, there was a significant increase in fish
consumption at 26 weeks (OR5 5.19; 95% CI, 1.51–17.91;
P 5 .009) consistent between intervention groups.
All groups improved in their ability to recognize demen-
tia symptoms depicted in a vignette (Supplementary Table 4)
but BBL1 FF improved more than control at 12 weeks only
(Table 3). Post hoc analysis of the changes within group indi-
cated significant changes in recognition between baseline
and 12 weeks for two intervention groups (BBL: P 5 .013;
BBL 1 FF: P 5 .002) and between baseline and 26 weeks
for the BBL 1 FF group (P 5 .028). All groups improved
on their knowledge on risk factors of dementia from baseline
to 12 weeks and baseline to 26 weeks.
Most participants completed all seven online modules in
the BBL1 FF (81%) and the BBL (72%) groups. Number of
modules completed did not differ between groups [c2 (6,
116) 5 5.03, P 5 .54]. One participant in the BBL 1 FF
and five participants in the BBL did not complete any mod-
ules but provided follow-up survey data and were retained in
the analyses under an intention-to-treat. Participants in the
BBL 1 FF and BBL completed more modules that were
Fig. 1. Flowchart for the body brain life (BBL) dementia risk reduction trial. The BBL trial used a 1:1:1 design in which participants were randomized to either
an online intervention only (BBL), an online plus face-to-face intervention (BBL1 FF), or to an active control (control) (controlling for increased computer use
and access to health information).
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Table 1
Baseline characteristics
Characteristics
Control
(n 5 60)
BBL 1 FF
(n 5 58)
BBL
(n 5 58)
Statistic,
P value
Age, mean (SD), y 55.5 (2.9) 55.4 (3.1) 55.6 (2.90) F (2, 173) 5 0.08, P 5 .921
Female sex, n (%) 32 (53.3) 31 (53.5) 30 (51.7) c2 5 0.01; P 5 .993
Education, mean (SD), y 18.6 (3.7) 18.0 (3.6) 17.7 (3.4) F (2, 173) 5 0.99, P 5 .374
Risk factors, n (%)
Overweight/obese BMI 44 (77.2) 46 (80.7) 41 (73.2) c2 5 1.35; P 5 .508
Diabetes 14 (23.3) 11 (19.3) 12 (21.1) c2 5 2.42; P 5 .298
Traumatic Brain Injury 2 (3.3) 5 (8.6) 4 (7.0) c2 5 2.06; P 5 .356
Depression 11 (18.3) 14 (24.1) 8 (13.8) c2 5 2.16; P 5 .340
Smoking 25 (41.7) 15 (25.9) 22 (37.9) c2 5 10.97; P 5 .004
Cholesterol 25 (41.7) 18 (31.6) 19 (33.3) c2 5 1.00; P 5 .607
Low social engagement 28 (46.7) 27 (46.6) 23 (39.7) c2 5 1.03; P 5 .596
Pesticide 18 (30.0) 14 (24.1) 16 (27.6) c2 5 0.04; P 5 .979
Education 1 (1.7) 3 (5.2) 3 (5.2) c2 5 3.17; P 5 .204
Protective Factors, n (%)
Cognitive engagement 26 (43.3) 21 (36.2) 20 (34.5) 2 5 1.08; P 5 .584
Alcohol 7 (11.7) 6 (10.34) 14 (24.1) 2 5 3.31; P 5 .191
Physical activity 54 (90.0) 50 (86.2) 50 (86.2) 2 5 0.82; P 5 .662
Fish consumption 48 (80.0) 48 (82.8) 47 (81.0) c2 5 1.24; P 5 .538
ADRI total score, mean (SD) 21.38 (5.67) 20.88 (4.39) 21.07 (6.21) F (2, 173) 5 0.13, P 5 .880
Dementia literacy score, mean (SD) 5.9 (2.25) 5.95 (2.04) 6.81 (1.37) F (2, 173) 5 4.12, P 5 .018
Abbreviations: BBL 1 FF, body brain life plus face-to-face; SD, standard deviation; BMI, body mass index; ADRI, Alzheimer’s disease risk index.
NOTE. There were no differences between groups on ADRI total score at baseline, although those in the BBL group did report slightly higher levels of de-
mentia literacy in comparison with the control (P 5 .017) and BBL 1 FF (P 5 .011).
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tors (mode 5 1), with no difference between groups on
either the number of protective [c2 (3, 116) 5 5.50,
P 5 .14] or risk [c2 (1, 116) 5 1.16, P 5 .28] modules
completed. Sensitivity analyses examining the impact of
the number and type of modules completed on ANU-
ADRI total, protective, and risk factor scores found no ef-
fects of adherence on results.4. Comment
In this first online trial of dementia risk reduction target-
ing middle-aged adults, we found high adherence to theTable 2
Differences in ANU-ADRI total, risk, and protective scores between randomizati
ANU-ADRI total Risk
b (SE) b (SE) b (S
Constant 0.03 (0.12) 20.05 (0.13) 0.0
Intervention group (ref. control)
BBL 1 FF 20.01 (0.17) 0.09 (0.18) 20.0
BBL 20.09 (0.17) 0.06 (0.18) 20.1
Time (ref. baseline)
12 wk 20.19 (0.07)** 20.07 (0.12) 20.0
26 wk 20.28 (0.07)*** 20.10 (0.12) 20.0
Intervention by occasion of measurement
12 wk – BBL 1 FF 20.18 (0.16)
12 wk – BBL 20.17 (0.16)
26 wk – BBL 1 FF 20.18 (0.13)
26 wk – BBL 20.37 (0.16)*
Abbreviations: ANU-ADRI, Australian National University-Alzheimer’s disease
NOTE. ***P , .001; **P , .01.study protocol among participants and that scores on the
ANU-ADRI reduced significantly from baseline, for both
the intervention groups, with stronger effects in the BBL
condition. The intervention effects were equivalent to the
reduction of approximately one risk factor. A key finding
from this study was that the benefits of the intervention
were specific to what we defined as “protective” factors.
Our findings suggest that improving protective behaviors
may be the easiest target for short-term, low-cost interven-
tions for dementia risk reduction. It is also possible to mea-
sure change in protective factors such as increasing fish
consumption over short periods. In comparison, reduction
in BMI and other chronic conditions is difficult to attainon group and measurement occasion
factor score Protective factor score
E) b (SE) b (SE) b (SE)
6 (0.12) 0.02 (0.13) 0.01 (0.12) 0.09 (0.13)
7 (0.17) 20.04 (0.18) 20.05 (0.16) 20.17 (0.18)
1 (0.17) 20.02 (0.18) 0.01 (0.16) 20.10 (0.18)
2 (0.05) 0.04 (0.09) 0.24 (0.07)** 0.13 (0.13)
1 (0.05) 0.07 (0.09) 0.37 (0.07)*** 0.19 (0.13)
20.05 (0.13) 0.22 (0.18)
20.14 (0.13) 0.10 (0.18)
20.06 (0.13) 0.20 (0.18)
20.18 (0.13) 0.33 (0.19)
risk index; SE, standard error; BBL1 FF, body brain life plus face-to-face.
Fig. 2. Effects of interventions on the total ANU-Alzheimer’s dementia risk
index (ANU-ADRI) score—primary outcome of change. The ANU-ADRI
scores decreased significantly over time, indicating risk reduction. Actual
scores shown. An intervention by time interaction indicated significantly
greater risk reduction for BBL 1 FF relative to control at time 3. Post
hoc analyses indicated significant reduction in risk at time 2 and 3 relative
to baseline for both intervention groups but not for the control group. P re-
flects a significance values.
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6 months.
Our data suggest that the inclusion of the face-to-face
component did not increase the intervention efficacy nor
did it increase adherence to the online intervention. This is
in contrast to research in domains such as obesity reduction
that have found that face-to-face interventions are more
effective [17]. Longer term follow-up, larger sample sizes,
and health economics analyses are required to further eval-
uate whether there are potential benefits to the additional
face-to-face component of the BBL intervention to deter-
mine whether its inclusion is warranted. It is possible that
the face-to-face component may benefit subgroups of partic-
ipants or specific risk or protective factors.
There are no similar completed trials in the literature. The
Finnish Geriatric Intervention Study to Prevent Cognitive
Impairment and Disability (FINGER) trial [18] which isTable 3
Differences in the likelihood of dementia recognition and risk factor knowledge s
Recognition
OR (SE) OR (SE)
Constant
Intervention group (ref. control)
BBL 1 FF 0.30 (0.12)** 0.14 (0.
BBL 0.44 (0.18) 0.23 (0.
Time (ref. baseline)
12 wk 4.14 (1.65)*** 0.87 (0.
26 wk 2.43 (0.83)** 1.22 (0.
Intervention by occasion of measurement
12 wk – BBL 1 FF 10.24 (10
12 wk – BBL 6.37 (6.
26 wk – BBL 1 FF 2.42 (2.
26 wk – BBL 2.42 (2.
Abbreviations: OR, odds ratio; SE, standard error; BBL 1 FF, body brain life
NOTE. ***P , .001; **P , .01; *P , .05.currently underway also aims to reduce risk in cognitively
healthy individuals, but unlike BBL, it targets older individ-
uals (60–77 years) who were recruited from earlier cross-
sectional studies. Moreover, it uses an intensive intervention
involving individualized dietary counseling, a physical ac-
tivity training program, monitored cognitive training ses-
sions, and intense monitoring and management of
metabolic risk factors. The Healthy Ageing Through
Internet Counselling in the Elderly program is an ongoing
European Union initiative to establish the efficacy of online
interventions to reduce cardiovascular risk factors and
cognitive decline (http://www.hatice.eu/). The investment
in this trial signals the potential significance of online inter-
ventions and the need to evaluate their efficacy.4.1. Strengths and weaknesses
Using a volunteer sample in this study selected out rela-
tively highly educated participants. Comparison with
population-based data showed that this sample had higher
risk scores indicating that it was at a relatively higher risk
of dementia compared with the population. The screening
method underidentified protective factors. Future trials
need to use more thorough screening methods and target
samples with low education and higher ANU-ADRI risk
scores for whom the intervention has been designed. We
expect that the educational components of BBL will be
more effective among adults who have low levels of educa-
tion and health literacy and who have higher initial ANU-
ADRI risk scores. The outcome measure was self-report
and may have been subject to reporting bias. It is possible
that time spent on the intervention influenced results. The
study was not sufficiently powered to detect significant dif-
ferences between BBL and BBL 1 FF. Although the BBL
intervention is inexpensive in absolute terms, we have not
evaluated its cost-effectiveness.cores between randomization group and measurement occasion
Knowledge on risk factors
b (SE) b (SE)
20.16 (0.08) 20.16 (0.10)
09)** 0.13 (0.11) 0.02 (0.15)
14) 0.36 (0.11)** 0.46 (0.15)**
67) 0.67 (0.08)*** 0.61 (0.14)***
95) 0.66 (0.08)*** 0.73 (0.14)***
.28)* 0.24 (0.20)
45) 20.05 (0.20)
37) 0.10 (0.20)
24) 20.33 (0.20)
plus face-to-face.
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dementia risk reduction trial with positive uptake of protec-
tive behaviors by participants. If participants do not change
their risk profile as they move into older age, their
ANU-ADRI scores will consequently increase. We expect
that the intervention will be more effective among younger
adults with high ANU-ADRI scores.
Although our outcome measure has been linked to de-
mentia in cohort studies, it is not specifically designed to
measure the more subtle aspects of behavioral and motiva-
tional change that may be precursors to risk reduction. De-
mentia risk reduction is a new field of research and we
know of no other outcome measures that could have been
used in this trial. However, there needs to be consideration
of adapting measures such as the ANU-ADRI to increase
their sensitivity. A limitation of our approach was that the
full ANU-ADRI score includes components that were not
affected by the intervention. Future research should only
include the items relating to risk and protective factors tar-
geted by the intervention.
Several of the risk factors on the ANU-ADRI are difficult
to change over short periods of time (e.g. high cholesterol). It
is possible that our trial elicited changes in behavior that
were not captured by our outcome measure. For example,
we do not know if participants became more aware of their
health status and chronic conditions during the trial which
may lead to healthier behavior choices and better disease
management in the long term.5. Conclusions
The study demonstrates the feasibility of an online demen-
tia risk reduction intervention incorporating behavior change
principles that resulted in a high level of adherence and an in-
crease in dementia literacy and protective behaviors. A face-
to-face component did not boost the efficacy of the online
intervention. These results hold promise for the further devel-
opment of online risk reduction interventions.
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1. Systematic review:We conducted a systematic -review
of the literature to identify dementia risk reduction tri-
als and online dementia risk reduction trials. No other
multidomain intervention to reduce risk of Alzheimer’s
disease or dementia has been conducted using online
methodology or in middle-aged adults.
2. Interpretation: Our study results show for the first time
that dementia risk reduction using an online interven-
tion is possible over a 6-month period. Increasing pro-
tective factors is achievable using low-cost
interventions. It is likely that this online intervention
will be more effective in participants who are at greater
risk and who have poorer baseline health literacy.
3. Future directions: Further research is required to
identify the strength and length of online interven-
tions required to reduce risk factors. Research needs
to identify methods for maintaining risk reduction
once it has been achieved and to develop interven-
tions tailored for specific population groups.
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